Acutaas Chemicals Limited (ACUTAAS) — key facts
NSE-listed · Basic Materials. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹3,866.6 (-1.54% day change)
Key ratios
- P/E ratio
- 88.87
- P/B ratio
- 12.67
- ROE (%)
- 21.54
- ROCE (%)
- 25.35
- Debt/Equity
- 0.02
- Dividend yield (%)
- 0.06
- Market cap (₹ Cr)
- 31,656.29
Forensic checks
Piotroski F-Score: 5/9 · Altman Z-Score: 13.26 · Beneish M-Score: -2.3
InvestSights quality score
70.7/100 — Above Average (descriptive data-driven composite; not a recommendation)
Latest earnings call (Q2 FY27)
AI summary: The most important signal was management’s decision to accelerate the CDMO milestone to ₹1,000 crores in FY27 and establish a new ₹2,000 crores by FY30 target, supported by orders, validated products and a broader pipeline. This is significant because the growth is expected while Ankleshwar Unit 2 remains at relatively early utilisation: management reported 30% utilisation in…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.